AstraZeneca jab has 76% efficacy against symptomatic Covid-19, study finds
AstraZeneca says its vaccine has 76% efficacy against symptomatic Covid-19, after the firm updated analysis of the third phase of testing.
Full Article
AstraZeneca jab has 76% efficacy against symptomatic Covid-19, study finds
Belfast Telegraph
0 shares
3 views
You might like
Related news coverage
US: AstraZeneca may have used outdated info in vaccine trial
SeattlePI.com
WASHINGTON (AP) — Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and..
-
The Latest: US says AstraZeneca info may have been outdated
SeattlePI.com
-
US: AstraZeneca may have used outdated info in vaccine trial
SeattlePI.com
-
Spain broadens use of AstraZeneca jab to adults under age 65
SeattlePI.com
-
AstraZeneca: US data shows vaccine effective for all ages
SeattlePI.com
Advertisement
More coverage
AstraZeneca Covid jab '100% effective in preventing severe illness', study finds
Daily Record
A study conducted in the US also found that it was 79% effective in preventing symptomatic cases of coronavirus.
